Skip to content

About
Services
- NLP
- AI & Knowledge Graphs
Blog
Contact

About
Services
- NLP
- AI & Knowledge Graphs
Blog
Contact

Identifying multiscale translational safety biomarkers using a network-based systems approach

Search

Browse more

Recent Posts

MedBioinformatics Announces Participation in IHI JU VICT3R Initiative to Revolutionize Nonclinical Drug and Chemical Safety Evaluation with Virtual Controls
Genetics In Drug Discovery: The Key To Clinical Trial Success?
DISGENET Academic License: Eligibility, Application & Free Access
How DISGENET Uses NLP To Accelerate Drug Development
DISGENET Rebrand: A Fresh Look, Same Reliable Data for Tomorrow

Archives

September 2024
August 2024
July 2024
June 2024
September 2023
March 2023
October 2022
May 2022

Categories

Article
Interview
News
Product

Tags

AI drug discovery software AI in healthcare am I eligible for the disgenet academic license? bioinformatics clinical trial success DISGENET disgenet.com disgenet academic license disgenet academic plans DISGENET for academics drug approvals drug development drug development software drug discovery drug repurposing drugs drug target selection FDA FDA approved drugs 2023 free access disgenet gene disease database genetic genetics genetic support for drug approvals genomics how is NLP used in drug discovery? human genetics improving drug target selection natural language processing new disgenet NLP NLP healthcare VICT3R VICT3R initiative

Identifying multiscale translational safety biomarkers using a network-based systems approach

Post navigation

Previous: eTRANSAFE: data science to empower translational safety assessment

Next: The human hepatocyte TXG- MAPr: gene co-expression network modules to support mechanism-based risk assessment

Contact
Careers
Privacy Policy
Cookies Policy

LinkedIn
YouTube
Mail

© Copyright 2024. MedBioinformatics Solutions.

Creativity & Web: Krieen